U.S. PET-CT Scanner Market– By Type, By Modality, By Slice Count, By Application, By End Use – Forecast, 2024 – 2032

U.S. PET-CT Scanner Market Size

U.S. PET-CT scanner market size was valued at around USD 864 million in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032. PET-CT scanner is a medical imaging device that combines positron emission tomography (PET) and computed tomography (CT) technologies into a single machine.
 

PET scans detect the metabolic activity of cells by using radioactive tracers, while CT scans provide detailed structural images. This simultaneous acquisition of functional and anatomical information helps in enhancing the diagnostic capabilities, particularly in oncology, cardiology, and neurology.
 

Rapid innovations, marked by frequent product launches aimed at enhancing imaging quality and reducing scan times, are propelling the growth of the U.S. PET-CT scanner market. Noteworthy advancements, such as the introduction of digital PET scanners boasting superior sensitivity and resolution, are set to significantly bolster this market's expansion. Furthermore, the U.S. healthcare system's focus on personalized medicine has spurred a heightened reliance on PET scans, especially for precise tumor localization and monitoring treatment responses.
 

Concurrently, cancer stands as the second leading cause of death in the U.S. The American Cancer Society forecasts around 2,001,140 new cancer cases and over 611,720 cancer-related deaths in 2024. This rising incidence underscores the urgency for enhanced diagnostic tools, propelling the demand and growth of the PET-CT scanner market.
 

Additionally, collaborations between technology companies and healthcare providers are driving research into new radiotracers. These radiotracers can target specific diseases more effectively, thus expanding the clinical applications of PET technology. For instance, in February 2024, IONETIX, a leader in cyclotron technology and isotope production, announced a partnership with Provision Diagnostic Imaging in Knoxville. The collaboration centered on the use of IONETIX's on-site production of N-13 Ammonia for cardiac PET/CT imaging. Provision Diagnostic Imaging, known for introducing advanced diagnostic technologies to East Tennessee, integrated this innovation to enhance its cardiac diagnostic services.
 

U.S. PET-CT Scanner Market Trends

• The market is experiencing growth due to the increasing prevalence of cancer and cardiovascular diseases. This trend is coupled with a growing adoption of digital imaging technology, which offers more comprehensive diagnostic capabilities.
   
• Advancements in PET-CT scanner technology have led to improved image quality and reduced scan times, enhancing patient comfort and diagnostic accuracy. These improvements are driving the rising demand for early and accurate disease diagnosis, particularly in oncology and neurology.
   
• The integration of artificial intelligence and machine learning in image analysis is revolutionizing the interpretation of PET-CT scans, leading to more precise diagnoses. This technological progress aligns with the broader shift towards personalized medicine and targeted therapies.
   
• Increasing investments in healthcare infrastructure and the modernization of imaging facilities are contributing to the expansion of the PET-CT scanner market in the United States. These investments enable healthcare providers to offer advanced diagnostic services to their patients.
   
• The growing emphasis on preventive healthcare and regular health screenings is boosting the demand for PET-CT scans as a proactive diagnostic tool. This trend is particularly evident in oncology, where early detection can significantly improve treatment outcomes.
   
• Advancements in radiopharmaceuticals are expanding the applications of PET-CT imaging. New tracers are being developed to target specific diseases or cellular processes, enhancing the diagnostic capabilities of PET-CT scanners across various medical specialties.
   
• The increasing adoption of value-based healthcare models is driving the demand for cost-effective diagnostic solutions. PET-CT scanners, with their ability to provide comprehensive diagnostic information in a single examination, are well-positioned to meet this demand.
   

U.S. PET-CT Scanner Market Analysis

Based on type, the market is segmented into digital and analog. The digital segment dominated the market with the largest revenue of USD 511.8 million in 2023 and is expected to grow at a significant CAGR over the forecast period.
 

• Digital PET-CT scanners, such as the Vereos PET/CT system, utilize advanced digital photon-counting technology, offering superior resolution, increased sensitivity, and long-term stability compared to traditional analog systems. The World Health Organization (WHO) emphasizes that such advancements in imaging technology are vital for early cancer detection and treatment. This progress is essential for improving the accuracy of cancer diagnoses and enhancing the ability to detect even the smallest lesions in patients.
   
• Additionally, the growing demand for precise imaging in oncology and cardiology further drives the adoption of digital systems. According to the Centers for Disease Control and Prevention (CDC), early and accurate cancer detection significantly enhances treatment outcomes. A February 2020 study published in EJNMMI Physics found that digital PET/CT systems outperform analog ones in identifying smaller lesions, with up to 37-44% higher maximum uptake values, boosting diagnostic confidence. This shift highlights the importance of integrating advanced imaging technologies into medical practice, leading to segmental growth.
   
• Furthermore, digital PET-CT systems offer operational advantages, including shorter scan times, reduced radiation exposure, and lower operational costs due to fewer hardware components. The American Hospital Association (AHA) reports that healthcare facilities are prioritizing cost reduction, making these systems an attractive option for U.S. medical centers. As a result, the adoption of digital PET-CT systems is expected to grow due to their efficiency and cost-effectiveness, driving the market growth over the forthcoming years.
   

Based on modality, the U.S. PET-CT scanner market is segmented into fixed and mobile. The mobile segment of the market, which held a 39.8% share in 2023, is poised for substantial growth in the coming years.
 

• PET-CT scanners play a crucial role in early cancer detection, staging, and treatment monitoring. Mobile PET-CT units extend these services to underserved or rural areas with limited access to advanced medical technology, enhancing comprehensive cancer care across diverse populations.
   
• Further, mobile PET-CT scanners address the needs of healthcare facilities lacking permanent imaging equipment. These mobile diagnostic solutions facilitate timely interventions, potentially improving patient outcomes.
   
• The shift towards outpatient care and value-based healthcare is further driving demand for cost-effective diagnostic solutions. Mobile PET-CT scanners allow healthcare providers to offer convenient services in outpatient settings while minimizing the expenses associated with constructing dedicated imaging centers. This approach aligns with the growing trend of delivering more efficient, patient-centered healthcare.
   
• Moreover, advancements in PET-CT technology, such as improved image quality, shorter scanning times, and reduced radiation exposure, have also made mobile units more appealing to healthcare providers. The U.S. Food and Drug Administration (FDA) continues to approve state-of-the-art PET-CT systems that feature reduced radiation doses and faster scan times. These innovations ensure that mobile units deliver diagnostic results comparable to stationary systems, further encouraging their adoption across various healthcare settings.
   
• Therefore, these factors are expected to augment segmental growth.
   

Based on slice count, the U.S. PET-CT scanner market is segmented into high slice, medium slice, and low slice. The medium slice segment of the market, which held a 52.3% share in 2023, is poised for substantial growth in the coming years.
 

• Medium-slice PET-CT scanners, which typically feature 16 to 64 detector slices, strike a balance between high image resolution and cost-effectiveness compared to high-slice models. These devices are vital in oncology, cardiology, and neurology, offering detailed images of metabolic activity alongside anatomical structures.
   
• Recent technological advancements have enhanced medium-slice PET-CT scanners by improving image quality, reducing scan times, and incorporating advanced software for precise quantification. These improvements make medium-slice scanners an attractive option for healthcare facilities seeking to upgrade their diagnostic capabilities without the financial burden associated with high-end systems.
   
• Medium-slice PET-CT scanners provide a more affordable alternative to higher-slice models while maintaining adequate resolution and functionality for various clinical applications. This cost-effectiveness is particularly appealing to smaller hospitals, outpatient centers, and facilities in rural areas. According to the CDC, rural Americans experience higher mortality rates from cancer, heart disease, unintentional injuries, chronic lower respiratory disease (CLRD), and stroke compared to urban populations. The availability of medium-slice PET-CT scanners in rural healthcare facilities could help mitigate this disparity by improving access to advanced diagnostic imaging.
   

Based on application, the U.S. PET-CT scanner market is segmented into cardiology, oncology, neurology, and other applications. The oncology segment dominated the market with the largest revenue of USD 697.2 million in 2023 and is expected to grow at a significant CAGR over the forecast period.
 

• The U.S. market for PET-CT scanners in oncology is shaped by several factors, including rising cancer rates, technological advancements, favorable reimbursement policies, and an aging population. As healthcare evolves, the significance of PET-CT in oncology diagnostics and treatment monitoring is expected to grow, bolstered by continuous innovations and increased healthcare accessibility.
   
• Additionally, the increasing prevalence of cancer in the U.S. drives the demand for advanced diagnostic imaging techniques. According to the National Cancer Institute, approximately 17,435,314 individuals were living with cancer in the U.S. in 2021. This high incidence rate highlights the urgent need for sophisticated imaging technologies such as PET-CT in oncology.
   
• Furthermore, the use of PET-CT in clinical trials for cancer therapies also contributes to market growth. Numerous research institutions and pharmaceutical companies depend on PET-CT scans to assess treatment efficacy and monitor cancer progression. The National Institutes of Health's clinical trial database lists many ongoing studies incorporating PET-CT in cancer research, further demonstrating its critical role in advancing cancer treatments.
   
• Moreover, the emergence of new therapies, such as cancer immunotherapy and personalized medicine to treat cancer, has escalated the need for advanced imaging to evaluate treatment responses. PET-CT is essential for assessing the effectiveness of these therapies. The U.S. Food and Drug Administration (FDA) has approved several immunotherapy drugs in recent years, which has heightened the demand for precise imaging techniques to monitor treatment outcomes.
   
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment over the forecast period.
   

Based on end-use, the market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, research institutes, and other end users. The hospitals segment of the market, which held a 59.1% share in 2023, is poised for substantial growth in the coming years.
 

• The U.S. market for PET-CT scanners in hospitals is shaped by several key factors, including the rising incidence of cancer, technological advancements, and an aging population. According to the National Cancer Institute, approximately 40.5% of men and women are expected to be diagnosed with cancer at some point in their lives, highlighting the critical role of PET-CT imaging in enhancing diagnostic capabilities, supporting personalized medicine, and improving patient outcomes. As these trends continue, the demand for PET-CT scanners in U.S. hospitals is expected to grow, reflecting the increasing need for advanced diagnostic tools in cancer care.
   
• The surge in healthcare service demand in hospital settings is also driven by hospitals' capacity to invest in technologically advanced equipment, thereby attracting patients seeking high-quality treatment. For instance, spending on hospital care services in the U.S. rose by 2.2% in 2022, reaching USD 1.4 trillion. This trend underscores the vital role of advanced diagnostic tools like PET-CT scanners in addressing the evolving healthcare needs of patients.
   
• Finally, growing public awareness of the significance of early diagnosis and advanced treatment options is driving higher patient demand for PET-CT scans. As patients become more informed about the benefits of comprehensive diagnostic imaging, their preferences influence hospital decisions regarding technology investments, thereby promoting further adoption of PET-CT scanners in healthcare facilities.
   

The Northeast zone dominated the U.S. PET-CT scanner market with the largest revenue of USD 177.1 million in 2023 and is projected to witness substantial growth over the forecast period.
 

• The Northeast U.S. boasts a robust healthcare infrastructure, with many academic medical centers, hospitals, and outpatient imaging centers integrating PET-CT technology into their diagnostic services. The National Cancer Institute's Cancer Centers Program includes several comprehensive cancer centers in the Northeast, such as Dana-Farber Cancer Institute in Boston and Memorial Sloan Kettering Cancer Center in New York, both of which heavily rely on advanced imaging technologies. The concentration of these specialized centers amplifies the demand for PET-CT scanners in the region.
   
• Moreover, the Northeast serves as a hub for medical research and clinical trials, with prominent institutions like Harvard Medical School, Johns Hopkins University, University of Pennsylvania, and Mount Sinai School of Medicine conducting studies that utilize advanced imaging modalities. PET-CT scanners are essential for evaluating treatment efficacy in oncology and neurology research.
   
• Furthermore, improved reimbursement policies for PET-CT scans by Medicare and private insurers are encouraging healthcare providers to adopt this technology. This financial support expands access to advanced diagnostic imaging for a broader patient population, potentially facilitating earlier disease detection and more effective treatment planning throughout the Northeast.
   
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment over the forecast period.
   

U.S. PET-CT Scanner Market Share

The market is dominated by some of the major market players. The market is competitive in nature, with major organizations, local small players, and start-ups joining the industry competition. The key industry players are consistently involved in creating new opportunities in the healthcare sector. Leading companies, such as Siemens Healthineers, Koninklijke Philips, and GE HealthCare, are among others maintaining a strong presence with extensive product portfolios of PET-CT scanners encompassing enhanced imaging, accuracy, increased advantages, and global market reach.
 

Continuous product launches by key players are driving the PET-CT scanner market, as these launches stimulate competition and differentiation within the market, prompting companies to invest in research and development to stay ahead of competitors and meet evolving market demands. This competitive environment fosters innovation and drives the development of new advantages, improved efficacy, and applications in PET-CT, benefiting patients and healthcare professionals.
 

U.S. PET-CT Scanner Market Companies

Some of the eminent market participants operating in the U.S. PET-CT Scanner industry include:

• Bruker Corporation
• Canon
• GE HealthCare
• Koninklijke Philips
• Mediso
• MinFound Medical Systems
• MR Solutions
• Neusoft Medical Systems
• Siemens Healthineers
• Shanghai United Imaging Healthcare
• SOFIE
   

U.S. PET-CT Scanner Industry News:

• In May 2023, GE HealthCare announced U.S. FDA clearance of its Precision DL, a new, revolutionary deep learning-based image processing software to enhance image quality in PET/CT. This approval enhanced the company's position in AI and diagnostic imaging market.
   
• In July 2022, Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation, announced its acquisition of NXC Imaging, a Minneapolis-based distributor and service provider of medical imaging equipment. This strategic move enhanced Canon's sales and service capabilities across the Upper Midwest.
   

U.S. PET-CT Scanner market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Digital
• Analog

Market, By Modality

• Fixed
• Mobile

Market, By Slice Count

• High slice
• Medium slice
• Low slice

Market, By Application

• Cardiology
• Oncology
• Neurology
• Other applications

Market, By End Use

• Hospitals
• Diagnostic centers
• Ambulatory surgical centers
• Research institutes
• Other end users

The above information is provided for the following zones:

• East North Central
• West South Central
• South Atlantic
• Northeast
• East South Central
• West North Central
• Pacific Central
• Mountain States